Regulus Therapeutics Inc. buy HC Wainwright
Start price
19.09.23
/
50%
€1.50
Target price
19.09.24
€8.41
Performance (%)
-7.33%
Price
14.08.24
€1.39
Summary
This prediction is currently active. With a performance of -7.33%, the BUY prediction for Regulus Therapeutics Inc. by HC_Wainwright is down slightly. This prediction currently runs until 19.09.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Regulus Therapeutics Inc. | 6.923% | 6.923% |
iShares Core DAX® | 2.821% | -1.953% |
iShares Nasdaq 100 | 5.285% | -5.092% |
iShares Nikkei 225® | 3.687% | -4.221% |
iShares S&P 500 | 3.577% | -2.240% |
Comments by HC_Wainwright for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Stopped prediction by HC_Wainwright for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.86
25.06.24
25.06.24
€9.34
25.06.25
25.06.25
-22.58%
14.08.24
14.08.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.26
06.05.24
06.05.24
€8.35
06.05.25
06.05.25
-36.28%
14.08.24
14.08.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.64
25.03.24
25.03.24
€8.30
25.03.25
25.03.25
-45.45%
14.08.24
14.08.24